In a report released today, James Fish from Piper Sandler reiterated a Hold rating on Cloudflare (NET – Research Report), with a price target ...

In a report released today, Ryan Todd from Piper Sandler maintained a Hold rating on TotalEnergies (TTE – Research Report), with a price target ...

Arizona State Retirement System lifted its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 0.8% in the ...

Charles Schwab Investment Management Inc. lowered its position in shares of Piper Sandler Companies (NYSE:PIPR – Free Report) by 0.1% in the fourth quarter, according to its most recent Form 13F ...

Atlas Energy Solutions launched at Piper Sandler with an Overweight rating, attracted to multiple growth avenues, ...

Myriad Genetics (NASDAQ:MYGN) traded higher on Wednesday after Piper Sandler upgraded the cancer test developer to Overweight ...

Short sellers have been increasing their bets, with short interest now accounting for 6.1% of the stock's available float.

Piper Sandler expects the bill to pass along party lines. "Once it makes it over to the Senate, at least eight Democrats will ...

Alo Yoga, a luxury activewear brand, plans to open a Mall of America store.

Daner Wealth Management LLC acquired 1,081 shares of Alphabet, valued at approximately $217,000, in Q4. Institutional ...

Fintel reports that on March 11, 2025, Piper Sandler upgraded their outlook for BankUnited (NYSE:BKU) from Neutral to ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Axsome Therapeutics ( AXSM – Research Report) today and set a price target of $148.00. The company’s shares closed yesterday at $118.78.